Antimicrobial treatment of hospital-acquired pneumonia

Clinics in Chest Medicine

Volumn 26, Issue 1, 2005, Pages 97-104

  Fagon, Jean Yves ^a   Chastre, Jean ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; GLYCOPEPTIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; ARTIFICIAL VENTILATION; BACTERIAL STRAIN; BACTERIUM CULTURE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; GRAM NEGATIVE INFECTION; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PNEUMONIA; POLYPHARMACY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; RISK FACTOR; TIMED DRUG RELEASE; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 15744394437     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2004.10.007     Document Type: Review

References (41)

1. D.E. Craven, K.A. Steger, and T.W. Barber Preventing nosocomial pneumonia: state of the art and perspectives for the 1990s Am J Med 91 1991 44S 53S
2. J.Y. Fagon, J. Chastre, and A.J. Hance Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay Am J Med 94 1993 281 288
3. M.H. Kollef, G. Sherman, and S. Ward Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients Chest 115 1999 462 474
4. P.K. Linden, A.W. Pasculle, and R. Manez Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E faecium Clin Infect Dis 22 1996 663 670
5. J.P. Quinn Clinical problems posed by multiresistant nonfermenting gram-negative pathogens Clin Infect Dis 27 Suppl 1 1998 S117 S124
6. Centers for Disease Control Staphylococcus aureus resistant to vancomycin: United States, 2002 MMWR Morb Mortal Wkly Rep 51 2002 565 566
7. J. Chastre, and J.Y. Fagon Ventilator-associated pneumonia Am J Respir Crit Care Med 165 2002 867 903
8. P. Montravers, J.Y. Fagon, and J. Chastre Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia Am Rev Respir Dis 147 1993 38 44
9. M.H. Kollef Appropriate empirical antibacterial therapy for nosocomial infections getting it right the first time Drugs 63 2003 2157 2168
10. A. Torres, R. Aznar, and J.M. Gatell Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients Am Rev Respir Dis 142 1990 523 528
11. R. Celis, A. Torres, and J.M. Gatell Nosocomial pneumonia: a multivariate analysis of risk and prognosis Chest 93 1988 318 324
12. J. Rello, M. Gallego, and D. Mariscal The value of routine microbial investigation in ventilator-associated pneumonia Am J Respir Crit Care Med 156 1997 196 200
13. F. Alvarez-Lerma Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit: ICU-Acquired Pneumonia Study Group Intensive Care Med 22 1996 387 394
14. M.H. Kollef, and S. Ward The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia Chest 113 1998 412 420
15. C. Clec'h, J.F. Timsit, and A. De Lassence Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity Intensive Care Med 30 2004 1327 1333
16. J.L. Trouillet, J. Chastre, and A. Vuagnat Ventilator-associated pneumonia caused by potentially drug-resistant bacteria Am J Respir Crit Care Med 157 1998 531 539
17. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995 Am J Respir Crit Care Med 153 1996 1711 1725
18. J. Rello, M. Sa-Borges, and H. Correa Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices Am J Respir Crit Care Med 160 1999 608 613
19. R.S. Evans, S.L. Pestotnik, and D.C. Classen A computer-assisted management program for antibiotics and other antiinfective agents N Engl J Med 338 1998 232 238
20. J. Hayon, C. Figliolini, and A. Combes Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia Am J Respir Crit Care Med 165 2002 41 46
21. J. Chastre, J.Y. Fagon, and M. Bornet-Lecso Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia Am J Respir Crit Care Med 152 1995 231 240
22. J.F. Timsit, C. Cheval, and B. Gachot Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia Intensive Care Med 27 2001 640 647
23. D.R. Baldwin, D. Honeybourne, and R. Wise Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance Antimicrob Agents Chemother 36 1992 1176 1180
24. C. Lamer, V. de Beco, and P. Soler Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients Antimicrob Agents Chemother 37 1993 281 286
25. G. Höffken, and M.S. Niederman Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU Chest 122 2000 2183 2196
26. R.J. Mangi, T. Greco, and J. Ryan Cefoperazone versus combination antibiotic therapy of hospital-acquired pneumonia Am J Med 84 1988 68 74
27. L.A. Mandell, L.E. Nicolle, and A.R. Ronald A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia J Antimicrob Chemother 12 Suppl A 1983 9 20
28. A. Cometta, S. Zinner, and R. de Bock Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer: The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer Antimicrob Agents Chemother 39 1995 445 452
29. M. Hilf, V.L. Yu, and J. Sharp Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients Am J Med 87 1989 540 546
30. J.A. Korvick, C.S. Bryan, and B. Farber Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy Antimicrob Agents Chemother 36 1992 2639 2644
31. J. Rello, D. Mariscal, and F. March Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection? Am J Respir Crit Care Med 157 1998 912 916
32. J. Chastre, M. Wolff, and J.Y. Fagon Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial JAMA 29 2003 2588 2598
33. R.B. Brown, J.A. Kruse, and G.W. Counts Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia Antimicrob Agents Chemother 34 1990 269 272
34. I. Goldstein, F. Wallet, and A. Nicolas-Robin Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets Am J Respir Crit Care Med 166 2002 1375 1381
35. J.J. Rahal, C. Urban, and D. Horn Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella JAMA 280 1998 1233 1237
36. M.H. Kollef, L. Sharpless, and J. Vlasnik The impact of nosocomial infections on patient outcomes following cardiac surgery Chest 112 1997 666 675
37. H. Seppala, T. Klaukka, and J. Vuopio-Varkila The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland: Finnish Study Group for Antimicrobial Resistance N Engl J Med 337 1997 441 446
38. M.H. Kollef, J. Vlasnik, and L. Sharpless Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia Am J Respir Crit Care Med 156 1997 1040 1048
39. D. Gruson, G. Hilbert, and F. Vargas Rotation and restricted use of antibiotics in a medical intensive care unit: impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria Am J Respir Crit Care Med 162 2000 837 843
40. E.H. Ibrahim, S. Ward, and G. Sherman Experience with a clinical guideline for the treatment of ventilator-associated pneumonia Crit Care Med 29 2001 1109 1115
41. J.Y. Fagon, J. Chastre, and M. Wolff Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial Ann Intern Med 132 2000 621 630